tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Balance Sheet

715 Followers

VistaGen Therapeutics Balance Sheet

VistaGen Therapeutics's total assets for Q3 2024 were $131.07M, an increase of 210.62% from the previous quarter. VTGN total liabilities were $7.78M for the fiscal quarter, a 18.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Assets
$ 21.09M$ 74.64M$ 108.28M$ 5.77M$ 14.01M
Total Liabilities
$ 9.01M$ 9.93M$ 16.30M$ 11.50M$ 6.94M
Total Equity Gross Minority
$ 12.08M$ 64.72M$ 91.97M$ -5.73M$ 7.08M
Total Capitalization
$ 14.21M$ 64.72M$ 91.98M$ -5.73M$ 7.08M
Preferred Stock Equity
---$ 4.00K$ 4.00K
Capital Lease Obligations
---$ 4.04M$ 9.30K
Currency in USD

VistaGen Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis